Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole
- PMID: 16608509
- PMCID: PMC1458348
- DOI: 10.1186/1471-2334-6-73
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole
Abstract
Background: Fungal mural endocarditis is a rare entity in which the antemortem diagnosis is seldom made. Seven cases of mural endocarditis caused by Candida spp. have been collected from literature and six of these patients died after treatment with amphotericin B.
Case presentation: We report a case of mural endocarditis diagnosed by transesophageal echocardiogram and positive blood cultures to Candida parapsilosis. Because blood cultures continued to yield C. parapsilosis despite caspofungin monotherapy, treatment with voriconazole was added.
Conclusion: This is the first description of successful treatment of C. parapsilosis mural endocarditis with caspofungin and voriconazole.
Figures
Similar articles
-
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.Am J Ophthalmol. 2005 Jan;139(1):135-40. doi: 10.1016/j.ajo.2004.08.077. Am J Ophthalmol. 2005. PMID: 15652837
-
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.Scand J Infect Dis. 2006;38(10):950-1. doi: 10.1080/00365540600617041. Scand J Infect Dis. 2006. PMID: 17008248
-
Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature.J Infect. 2006 Jul;53(1):e11-4. doi: 10.1016/j.jinf.2005.10.003. Epub 2005 Nov 7. J Infect. 2006. PMID: 16274746 Review.
-
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.J Clin Microbiol. 2006 May;44(5):1912-4. doi: 10.1128/JCM.44.5.1912-1914.2006. J Clin Microbiol. 2006. PMID: 16672439 Free PMC article.
-
Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.Eur J Clin Microbiol Infect Dis. 2005 Nov;24(11):753-5. doi: 10.1007/s10096-005-0038-2. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16283214 Review.
Cited by
-
Salmonella Endocarditis: Rare Bacteremia Causing Mural Infective Endocarditis.Case Rep Infect Dis. 2025 Apr 14;2025:3830316. doi: 10.1155/crdi/3830316. eCollection 2025. Case Rep Infect Dis. 2025. PMID: 40260399 Free PMC article.
-
Mural Endocarditis: The GAMES Registry Series and Review of the Literature.Infect Dis Ther. 2021 Dec;10(4):2749-2764. doi: 10.1007/s40121-021-00490-y. Epub 2021 Jul 26. Infect Dis Ther. 2021. PMID: 34312819 Free PMC article.
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757. Clin Infect Dis. 2009. PMID: 19191635 Free PMC article.
-
Role of Antifungal Combinations in Difficult to Treat Candida Infections.J Fungi (Basel). 2021 Sep 6;7(9):731. doi: 10.3390/jof7090731. J Fungi (Basel). 2021. PMID: 34575770 Free PMC article. Review.
-
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.Antimicrob Agents Chemother. 2010 May;54(5):2244-7. doi: 10.1128/AAC.01527-09. Epub 2010 Mar 1. Antimicrob Agents Chemother. 2010. PMID: 20194697 Free PMC article.
References
-
- Bierbrier GS, Novick RJ, Guiraudon C, Wisenberg G, Boughner D. Left atrial bacterial mural endocarditis. Chest. 1991;99:757–759. - PubMed
-
- Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med. 1994;121:219–230. - PubMed
-
- Mullen P, Jude C, Borkon M, Porterfield J, Walsh TJ. Aspergillus mural endocarditis. Clinical and echocardiographic diagnosis. Chest. 1986;90:451–452. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous